Thiol supplementation inhibits metalloproteinase activity independent of glutathione status

Biochemical and Biophysical Research Communications

Volumn 363, Issue 3, 2007, Pages 651-655

  Bogani, Paola ^a,b   Canavesi, Monica ^a   Hagen, Tory M ^c   Visioli, Francesco ^d   Bellosta, Stefano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c OREGON STATE UNIVERSITY   (United States)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Antioxidant; Gelatinase; Metalloproteinase; MMP; Reactive oxygen species; Thiol

Indexed keywords

ACETYLCYSTEINE; GELATINASE; GELATINASE A; GELATINASE B; GLUTATHIONE; MATRIX METALLOPROTEINASE; THIOCTIC ACID; THIOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUTATHIONE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOPROTEASES; SULFHYDRYL COMPOUNDS; THIOCTIC ACID;

EID: 34948842470     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.018     Document Type: Article

References (36)

1. Dollery C.M., McEwan J.R., and Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77 (1995) 863-868
2. Dell'gli M., Canavesi M., Galli G., and Bellosta S. Dietary polyphenols and regulation of gelatinase expression and activity. Thromb. Haemost. 93 (2005) 751-760
3. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92 (1995) 402-406
4. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
5. Lijnen H.R. Extracellular proteolysis in the development and progression of atherosclerosis. Biochem. Soc. Trans. 30 (2002) 163-167
6. Herron G.S., Unemori E., Wong M., Rapp J.H., Hibbs M.H., and Stoney R.J. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler. Thromb. 1 (1991) 1667-1677
7. Eldrup N., Gronholdt M.L., Sillesen H., and Nordestgaard B.G. Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114 (2006) 1847-1854
8. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98 (1996) 2572-2579
9. Woods Jr. J.R. Reactive oxygen species and preterm premature rupture of membranes-a review. Placenta 22 Suppl A (2001) S38-S44
10. Galis Z.S., Asanuma K., Godin D., and Meng X. N-Acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?. Circulation 97 (1998) 2445-2453
11. Oak M.H., Chataigneau M., Keravis T., Chataigneau T., Beretz A., Andriantsitohaina R., Stoclet J.C., Chang S.J., and Schini-Kerth V.B. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1001-1007
12. Oak M.H., El Bedoui J., Anglard P., and Schini-Kerth V.B. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 110 (2004) 1861-1867
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
14. Bellosta S., Via D., Canavesi M., Pfister P., Fumagalli R., Paoletti R., and Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1671-1678
15. Bellosta S., Dell'gli M., Canavesi M., Mitro N., Monetti M., Crestani M., Verotta L., Fuzzati N., Bernini F., and Bosisio E. Inhibition of metalloproteinase-9 activity and gene expression by polyphenolic compounds isolated from the bark of Tristaniopsis calobuxus (Myrtaceae). Cell. Mol. Life Sci. 60 (2003) 1440-1448
16. Dell'gli M., Bellosta S., Rizzi L., Galli G.V., Canavesi M., Rota F., Parente R., Bosisio E., and Romeo S. A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate. Cell. Mol. Life Sci. (2005)
17. Jones D.P., Carlson J.L., Samiec P.S., Sternberg Jr. P., Mody Jr. V.C., Reed R.L., and Brown L.A. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 275 (1998) 175-184
18. Deneke S.M., and Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 257 (1989) L163-L173
19. Issels R.D., and Nagele A. Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells. Cancer Res. 49 (1989) 2082-2086
20. Sen C.K. Glutathione homeostasis in response to exercise training and nutritional supplements. Mol. Cell. Biochem. 196 (1999) 31-42
21. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253 (2003) 269-285
22. Berton A., Rigot V., Huet E., Decarme M., Eeckhout Y., Patthy L., Godeau G., Hornebeck W., Bellon G., and Emonard H. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. J. Biol. Chem. 276 (2001) 20458-20465
23. Bourraindeloup M., Adamy C., Candiani G., Cailleret M., Bourin M.C., Badoual T., Su J.B., Adubeiro S., Roudot-Thoraval F., Dubois-Rande J.L., Hittinger L., and Pecker F. N-Acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110 (2004) 2003-2009
24. Lappas M., Permezel M., and Rice G.E. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J. Clin. Endocrinol. Metab. 88 (2003) 1723-1729
25. Rahman I., and MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277 (1999) L1067-L1088
26. Rahman I., and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free. Radic. Biol. Med. 28 (2000) 1405-1420
27. Sochman J. N-Acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?. J. Am. Coll. Cardiol. 39 (2002) 1422-1428
28. Hultberg B., Andersson A., and Isaksson A. Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology 156 (2001) 93-100
29. Hultberg B., Andersson A., and Isaksson A. Lipoic acid increases glutathione production and enhances the effect of mercury in human cell lines. Toxicology 175 (2002) 103-110
30. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., and Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 11 (2004) 1135-1146
31. Arrigo A.P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27 (1999) 936-944
32. Brown L.A. Glutathione protects signal transduction in type II cells under oxidant stress. Am. J. Physiol. 266 (1994) L172-L177
33. Marracci G.H., McKeon G.P., Marquardt W.E., Winter R.W., Riscoe M.K., and Bourdette D.N. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J. Neurosci. Res. 78 (2004) 362-370
34. Massova I., Kotra L.P., Fridman R., and Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12 (1998) 1075-1095
35. Sen C.K. Cellular thiols and redox-regulated signal transduction. Curr. Top. Cell. Regul. 36 (2000) 1-30
36. Cantin A.M., Martel M., Drouin G., and Paquette B. Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid. Can J. Physiol. Pharmacol. 83 (2005) 301-308